Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Supplemental disclosure for statement of cash flows

Supplemental disclosure for statement of cash flows	6 Months Ended
Jan. 31, 2014
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	Note 3 - Supplemental disclosure for statement of cash flows For the six months ended January 31, 2014 and 2013, income taxes paid by the Company were $17 and $46, respectively. For the six months ended January 31, 2014 and 2013, interest paid by the Company was $114 and $15, respectively. For the six months ended January 31, 2014 and 2013, the Company financed $154 and $115 respectively, in machinery and transportation equipment under installment loans. For the six months ended January 31, 2014, 0 capital leases were entered into. For the six months ended January 31, 2013, the Company entered into a capital lease for machinery and equipment with a cost basis of $768.

Supplemental disclosure for statement of cash flows

6 Months Ended

Jan. 31, 2014

Supplemental Cash Flow Elements [Abstract]

Cash Flow, Supplemental Disclosures [Text Block]

Note 3 - Supplemental disclosure for statement of cash flows

For the six months ended January 31, 2014 and 2013, income taxes paid by the Company were $17 and $46, respectively.

For the six months ended January 31, 2014 and 2013, interest paid by the Company was $114 and $15, respectively.

For the six months ended January 31, 2014 and 2013, the Company financed $154 and $115 respectively, in machinery and transportation equipment under installment loans.

For the six months ended January 31, 2014, 0 capital leases were entered into. For the six months ended January 31, 2013, the Company entered into a capital lease for machinery and equipment with a cost basis of $768.